Vaxcyte (PCVX) earnings

Earnings (net income) · fiscal 2025
-$766.63M

Vaxcyte (PCVX) reported net income of -$766.63M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$463.93M. Figures as of 18 Nov 2026, 04:00 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
-$766.63M
Highest on record
-$29.49Mfiscal 2018
Lowest on record
-$766.63Mfiscal 2025
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Vaxcyte earnings, in more detail

Across the 8 fiscal years on record (2018–2025), the highest was -$29.49M in fiscal 2018 and the lowest -$766.63M in fiscal 2025.

History · 8 fiscal years

Earnings (net income) by fiscal year

Vaxcyte earnings, year by year

Vaxcyte (PCVX) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025-$766.63M—
2024-$463.93M—
2023-$402.27M—
2022-$223.49M—
2021-$100.08M—
2020-$89.22M—
2019-$50.27M—
2018-$29.49M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Vaxcyte and comparable companies
CompanyEarnings (net income)Fiscal year
Avantor AVTR-$530.20M2025
Ensign Group ENSG$343.97M2025
Vaxcyte PCVX-$766.63M2025
Bio-Rad Laboratories BIO$759.90M2025
Molina Healthcare MOH$472.00M2025
Spyre Therapeutics SYRE-$155.20M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PCVX

Vaxcyte, figure by figure

Vaxcyte (PCVX) overview: price, valuation and scorecardAll health care companies by market value

Vaxcyte earnings: questions and answers

What is Vaxcyte's net income?

Vaxcyte (PCVX) reported net income of -$766.63M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$463.93M.

What are the highest and lowest net income figures on record for Vaxcyte?

Across the 8 fiscal years on record (2018–2025), the highest was -$29.49M in fiscal 2018 and the lowest -$766.63M in fiscal 2025.

How is Vaxcyte's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Vaxcyte (PCVX) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/PCVX/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.